Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 2;7(1):1731277.
doi: 10.1080/20018525.2020.1731277. eCollection 2020.

Optimizing COPD treatment in patients with lung- or head and neck cancer does not improve quality of life - a randomized, pilot, clinical trial

Magnus Gottlieb  1 , Anders Mellemgaard  2 , Kristoffer Marsaa  3 , Nina Godtfredsen  1   4
Affiliations

Optimizing COPD treatment in patients with lung- or head and neck cancer does not improve quality of life - a randomized, pilot, clinical trial

Magnus Gottlieb et al. Eur Clin Respir J. .

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a common comorbidity in patients with lung and head- and neck cancer. Patients with lung cancer who also suffer from COPD have a worse prognosis than patients with lung cancer and no COPD. It has previously been shown that diagnosis and treatment of concomitant COPD in patients with newly diagnosed lung- or head and neck cancer need optimization. In this randomized, controlled trial we aimed to assess if intervention directed at improving treatment for COPD in these patients improved health-related quality of life (QoL). Methods: During 2014, we randomized 114 patients referred for oncological treatment at a large university hospital in the Capital Region of Denmark, to either usual care or intervention regarding concomitant COPD. The intervention consisted of two visits in an out-patient clinic established at the oncological department and staffed with a pulmonary physician. At baseline, week 13 and week 25, all patients filled out the cancer- and COPD-specific QoL questionnaires CAT and EORTC, respectively. The primary outcome was change in CAT-score between control- and intervention group. The secondary outcome was change in EORTC. Results: There was no change in CAT-score by week 13 or 25 between the groups. For the EORTC there was a statistically significant improvement only in the fatigue domain at week 13 (p = 0.03), but not at week 25. There was a trend towards less dyspnea in the intervention group at week 13, measured by EORTC (p = 0.07). Mortality by week 25 was similar in both groups. Conclusion: In this population of severely ill cancer patients, we did not find that this intervention, focusing on inhaled COPD medication, for the management of COPD had any convincing positive impact on the patients' perceived quality of life compared with usual care. Further studies are needed.

Keywords: COPD; comorbidity; lung cancer.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1.
Figure 1.
Consort flowchart of inclusion and follow up
See this image and copyright information in PMC

References

    1. [cited 2019. April 4]. Available from: https://goldcopd.org/.
    1. Miravitlles M, Ribera A.. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67. - PMC - PubMed
    1. Lim RB. End-of-life care in patients with advanced lung cancer. Ther Adv Respir Dis. 2016;10(5):455–8. - PMC - PubMed
    1. Mason H, DeRubeis MB, Burke N, et al. Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future research. World J Clin Oncol. 2016;7(2):220–226. - PMC - PubMed
    1. Chaukar DA, Walvekar RR, Das AK, et al. Quality of life in head and neck cancer survivors: a cross-sectional survey. Am J Otolaryngol. 2009;30(3):176–180. - PubMed

LinkOut - more resources